Goldline Pharmaceutical Limited SME
GOLDLINE · BSE · Upcoming
· goldlinepharma.in
Price range
₹41–43
GMP
% vs. upper price band
+₹17.00
(+39.5%)
Lot size
3000 shares
Issue size
₹11.61 Cr
Timeline
Open
12 May 2026
Close
14 May 2026
Allotment
15 May 2026
Settlement
18 May 2026
Listing
19 May 2026
Mandate end
29 May 2026
Anchor 50%
14 Jun 2026
Anchor 100%
13 Aug 2026
Note: The timeline is tentative. Anchor unlock dates apply only to IPOs with an anchor allotment.
Subscription
just now
| Quota | Shares offered (₹ Cr) |
Shares applied (₹ Cr) |
Times subscribed |
|---|---|---|---|
| QIB | 2.32 | 0.00 | - |
| NII | 1.68 | 0.00 | - |
| IND | 3.87 | 0.00 | - |
| Total | 7.87 | 0.00 | - |
| Quota | Applications reserved |
Applications received |
Times subscribed |
|---|---|---|---|
| QIB | 180 | 0 | - |
| NII | 43 | 0 | - |
| IND | 150 | 0 | - |
| Total | 373 | 0 | - |
Intermediaries
- Lead manager
- Cumulative Capital
- Registrar
- Bigshare Services
- Market maker
- Nirman Share Brokers